UniProt ID | NOL3_HUMAN | |
---|---|---|
UniProt AC | O60936 | |
Protein Name | Nucleolar protein 3 {ECO:0000312|HGNC:HGNC:7869} | |
Gene Name | NOL3 {ECO:0000312|HGNC:HGNC:7869} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 208 | |
Subcellular Localization |
Isoform 1: Nucleus, nucleolus . The SR-rich C-terminus mediates nuclear localization. Isoform 3: Cytoplasm . Isoform 2: Cytoplasm . Mitochondrion . Sarcoplasmic reticulum . Membrane Lipid-anchor . Phosphorylation at Thr-149 results in transl |
|
Protein Description | Isoform 1: May be involved in RNA splicing.; Isoform 2: Functions as an apoptosis repressor that blocks multiple modes of cell death. Inhibits extrinsic apoptotic pathways through two different ways. Firstly by interacting with FAS and FADD upon FAS activation blocking death-inducing signaling complex (DISC) assembly (By similarity). Secondly by interacting with CASP8 in a mitochondria localization- and phosphorylation-dependent manner, limiting the amount of soluble CASP8 available for DISC-mediated activation (By similarity). Inhibits intrinsic apoptotic pathway in response to a wide range of stresses, through its interaction with BAX resulting in BAX inactivation, preventing mitochondrial dysfunction and release of pro-apoptotic factors. [PubMed: 15004034 Inhibits calcium-mediated cell death by functioning as a cytosolic calcium buffer, dissociating its interaction with CASP8 and maintaining calcium homeostasis] | |
Protein Sequence | MGNAQERPSETIDRERKRLVETLQADSGLLLDALLARGVLTGPEYEALDALPDAERRVRRLLLLVQGKGEAACQELLRCAQRTAGAPDPAWDWQHVGPGYRDRSYDPPCPGHWTPEAPGSGTTCPGLPRASDPDEAGGPEGSEAVQSGTPEEPEPELEAEASKEAEPEPEPEPELEPEAEAEPEPELEPEPDPEPEPDFEERDESEDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGNAQERPS ------CCCCCCCCC | 37.87 | 25255805 | |
17 | Ubiquitination | ETIDRERKRLVETLQ HHHHHHHHHHHHHHH | 45.38 | PubMed | |
22 | Phosphorylation | ERKRLVETLQADSGL HHHHHHHHHHHCCHH | 19.38 | 20068231 | |
27 | Phosphorylation | VETLQADSGLLLDAL HHHHHHCCHHHHHHH | 34.06 | 20068231 | |
68 | Ubiquitination | LLLLVQGKGEAACQE HHHHHCCCHHHHHHH | 36.16 | PubMed | |
83 | Phosphorylation | LLRCAQRTAGAPDPA HHHHHHHHCCCCCCC | 19.84 | - | |
83 (in isoform 1) | Phosphorylation | - | 19.84 | 24719451 | |
104 | Phosphorylation | GPGYRDRSYDPPCPG CCCCCCCCCCCCCCC | 1.70 | 20068231 | |
105 | Phosphorylation | PGYRDRSYDPPCPGH CCCCCCCCCCCCCCC | 13.46 | 20068231 | |
109 (in isoform 1) | Phosphorylation | - | 21.09 | 24719451 | |
114 | Phosphorylation | PPCPGHWTPEAPGSG CCCCCCCCCCCCCCC | 20.68 | 25159151 | |
120 | Phosphorylation | WTPEAPGSGTTCPGL CCCCCCCCCCCCCCC | 47.59 | 20068231 | |
122 | Phosphorylation | PEAPGSGTTCPGLPR CCCCCCCCCCCCCCC | 41.71 | 20068231 | |
123 | Phosphorylation | EAPGSGTTCPGLPRA CCCCCCCCCCCCCCC | 40.16 | 20068231 | |
131 | Phosphorylation | CPGLPRASDPDEAGG CCCCCCCCCCCCCCC | 37.90 | 28985074 | |
142 | Phosphorylation | EAGGPEGSEAVQSGT CCCCCCCCHHHHCCC | 8.33 | 26699800 | |
147 | Phosphorylation | EGSEAVQSGTPEEPE CCCHHHHCCCCCCCC | 57.72 | 30278072 | |
149 (in isoform 1) | Phosphorylation | - | 35.15 | 23403867 | |
149 | Phosphorylation | SEAVQSGTPEEPEPE CHHHHCCCCCCCCHH | 35.15 | 28355574 | |
151 (in isoform 1) | Phosphorylation | - | 27.68 | 23403867 | |
162 | Phosphorylation | PELEAEASKEAEPEP HHHHHHHHHCCCCCC | 6.29 | 27251275 | |
163 | Ubiquitination | ELEAEASKEAEPEPE HHHHHHHHCCCCCCC | 43.87 | PubMed | |
176 (in isoform 3) | Phosphorylation | - | 7.64 | 27251275 | |
205 | Phosphorylation | DFEERDESEDS---- CHHHCCCCCCC---- | 45.88 | 28348404 | |
208 | Phosphorylation | ERDESEDS------- HCCCCCCC------- | 37.79 | 28348404 | |
209 (in isoform 3) | Phosphorylation | - | 45.09 | 27251275 | |
267 (in isoform 3) | Phosphorylation | - | 27251275 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
149 | T | Phosphorylation |
| - |
149 | T | Phosphorylation |
| - |
149 | T | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NOL3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NOL3_HUMAN | NOL3 | physical | 16189514 | |
SHPS1_HUMAN | SIRPA | physical | 16189514 | |
NIF3L_HUMAN | NIF3L1 | physical | 16189514 | |
EKI2_HUMAN | ETNK2 | physical | 16189514 | |
SRSF9_HUMAN | SRSF9 | physical | 10196175 | |
EHD4_HUMAN | EHD4 | physical | 22863883 | |
NOL3_HUMAN | NOL3 | physical | 25416956 | |
DAXX_HUMAN | DAXX | physical | 27488634 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...